Concepedia

Author

James L. Murray

The University of Texas MD Anderson Cancer Center

Also Known As

J L Murray, James L. Murray

8

Publications

221

Citations

7

H-Index

27

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterBreast Cancer Care
JL

About

James L. Murray is an author at The University of Texas MD Anderson Cancer Center specializing in cancer research, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

140

2

Immunology

3

3

69

3

Pathology

2

2

46

4

Health Sciences

1

1

71

5

Biochemistry

1

1

71

James L. Murray

×

7

Publications

220

Citations

7

H-Index

YearCitations

Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance.

Brian L. Samuels, James L. Murray, M. Cohen,

PubMed

1991

71

Phase Ia/Ib Trial of Anti-GD2 Chimeric Monoclonal Antibody 14.18 (ch l4.18) and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhGM-CSF) in Metastatic Melanoma

James L. Murray, Eugenie Kleinerman, Shu-Fang Jia,

Journal of Immunotherapy

1996

39

Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.

Daniel J. Macey, Edward Grant, Leela P. Kasi,

PubMed

1997

36

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma

Nuhad K. Ibrahim, Zia Ur Rahman, Vicente Valero,

Cancer

1999

23

Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin.

Kapil Dhingra, Herbert A. Fritsche, James L. Murray,

PubMed

1995

23

Comparative tumor localization of whole immunoglobulin g anticarcinoembryonic antigen monoclonal antibodies immu-4 and immu-4 f(ab′)2 in colorectal cancer patients

James L. Murray, Michael G. Rosenblum, Hua-Zhong Zhang,

Cancer

1994

18

Clinical pharmacology and tissue disposition studies of131I-labeled anticolorectal carcinoma human monoclonal antibody LiCO 16.88

M. G. Rosenblum, Bernard Levin, Mark Roh,

Cancer Immunology Immunotherapy

1994

10

Page 1